Biochemistry of storage lesions of red cell and platelet concentrates: A continuous fight implying oxidative/nitrosative/phosphorylative stress and signaling

Transfusion and Apheresis Science

Volumn 52, Issue 3, 2015, Pages 262-269

  Rinalducci, Sara ^a   Zolla, Lello ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; NITRIC OXIDE; THIOL; THROMBOCYTE CONCENTRATE; NITROGEN; OXYGEN; THIOL DERIVATIVE;

BLOOD BIOCHEMISTRY; CELL DAMAGE; CELLULAR STRESS SIGNAL; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE PRESERVATION; GLYCATION; HUMAN; NITROSATIVE STRESS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PLATELET STORAGE LESION; PROTEIN CARBONYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RED BLOOD CELL STORAGE LESION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE PRESERVATION; ANIMAL; BLOOD STORAGE; CHEMISTRY; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; METABOLISM; PHOSPHORYLATION; PROCEDURES; PROTEOMICS; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

ANIMALS; BLOOD PLATELETS; BLOOD PRESERVATION; ERYTHROCYTE COUNT; ERYTHROCYTE MEMBRANE; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; NITRIC OXIDE; NITROGEN; OXIDATIVE STRESS; OXYGEN; PHOSPHORYLATION; PLATELET TRANSFUSION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; SIGNAL TRANSDUCTION; SULFHYDRYL COMPOUNDS;

EID: 84930537629     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2015.04.005     Document Type: Review

References (100)

1. Sharma S., Sharma P., Tyler L.N. Transfusion of blood and blood products: indications and complications. Am Fam Physician 2011, 83:719-724.
2. Devine D.V., Serrano K. The platelet storage lesion. Clin Lab Med 2010, 30:475-487.
3. Lion N., Crettaz D., Rubin O., Tissot J.D. Stored red blood cells: a changing universe waiting for its map(s). J. Proteomics 2010, 73:374-385.
4. D'Alessandro A., Kriebardis A.G., Rinalducci S., Antonelou M.H., Hansen K.C., Papassideri I.S., et al. An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. Transfusion 2014, 10.1111/trf.12804.
5. Schubert P., Devine D.V. Towards targeting platelet storage lesion-related signaling pathways. Blood Transfus 2014, 8:s69-72.
6. Longo V., Marrocco C., Zolla L., Rinalducci S. Label-free quantitation of phosphopeptide changes in erythrocyte membranes: towards molecular mechanisms underlying deformability alterations in stored red blood cells. Haematologica 2014, 99:e122-5.
7. Kanias T., Acker J.P. Biopreservation of red blood cells-the struggle with hemoglobin oxidation. FEBS J 2010, 277:343-356.
8. Jóźwik M., Jóźwik M., Jóźwik M., Szczypka M., Gajewska J., Laskowska-Klita T. Antioxidant defence of red blood cells and plasma in stored human blood. Clin Chim Acta 1997, 267:129-142.
9. Deepa Devi K.V., Manoj Kumar V., Arun P., Santhosh A., Padmakumaran Nair K.G., Lakshmi L.R., et al. Increased lipid peroxidation of erythrocytes in blood stored in polyvinyl chloride blood storage bags plasticized with di-[2-ethyl hexyl] phthalate and effect of antioxidants. Vox Sang 1998, 75:198-204.
10. Bosman G.J., Stappers M., Novotný V.M. Changes in band 3 structure as determinants of erythrocyte integrity during storage and survival after transfusion. Blood Transfus 2010, 8:s48-52.
11. Kim-Shapiro D.B., Lee J., Gladwin M.T. Storage lesion: role of red blood cell breakdown. Transfusion 2011, 51:844-851.
12. Azarov I., Liu C., Reynolds H., Tsekouras Z., Lee J.S., Gladwin M.T., et al. Mechanisms of slower nitric oxide uptake by red blood cells and other hemoglobin-containing vesicles. J Biol Chem 2011, 286:33567-33579.
13. Liu C., Zhao W., Christ G.J., Gladwin M.T., Kim-Shapiro D.B. Nitric oxide scavenging by red cell microparticles. Free Radic Biol Med 2013, 65:1164-1173.
14. Azarov I., Huang K.T., Basu S., Gladwin M.T., Hogg N., Kim-Shapiro D.B. Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J Biol Chem 2005, 280:39024-39032.
15. Vaughn M.W., Huang K.T., Kuo L., Liao J.C. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem 2000, 275:2342-2348.
16. Butler A.R., Megson I.L., Wright P.G. Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta 1998, 1425:168-176.
17. Liao J.C., Hein T.W., Vaughn M.W., Huang K.T., Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci USA 1999, 96:8757-8761.
18. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001, 357:593-615.
19. Aubron C., Nichol A., Cooper D.J., Bellomo R. Age of red blood cells and transfusion in critically ill patients. Ann. Intensive Care 2013, 3:2.
20. Alexander J.T., El-Ali A.M., Newman J.L., Karatela S., Predmore B.L., Lefer D.J., et al. Red blood cells stored for increasing periods produce progressive impairments in nitric oxide-mediated vasodilation. Transfusion 2013, 53:2619-2628.
21. Stapley R., Owusu B.Y., Brandon A., Cusick M., Rodriguez C., Marques M.B., et al. Erythrocyte storage increases rates of NO and nitrite scavenging: implications for transfusion-related toxicity. Biochem J 2012, 446:499-508.
22. Liu C., Liu X., Janes J., Stapley R., Patel R.P., Gladwin M.T., et al. Mechanism of faster NO scavenging by older stored red blood cells. Redox Biol 2014, 2:211-219.
23. Blasi B., D'Alessandro A., Ramundo N., Zolla L. Red blood cell storage and cell morphology. Transfus Med 2012, 22:90-96.
24. Donadee C., Raat N.J., Kanias T., Tejero J., Lee J.S., Kelley E.E., et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011, 124:465-476.
25. Ferranti P., Malorni A., Mamone G., Sannolo N., Marino G. Characterisation of S-nitrosohaemoglobin by mass spectrometry. FEBS Lett 1997, 400:19-24.
26. Allen B.W., Piantadosi C.A. How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm. Am J Physiol Heart Circ Physiol 2006, 291:H1507-12.
27. Chen K., Popel A.S. Nitric oxide production pathways in erythrocytes and plasma. Biorheology 2009, 46:107-119.
28. Reynolds J.D., Ahearn G.S., Angelo M., Zhang J., Cobb F., Stamler J.S. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci USA 2007, 104:17058-17062.
29. Bennett-Guerrero E., Veldman T.H., Doctor A., Telen M.J., Ortel T.L., Reid T.S., et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007, 104:17063-17068.
30. Bor-Kucukatay M., Wenby R.B., Meiselman H.J., Baskurt O.K. Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 2003, 284:H1577-84.
31. Kleinbongard P., Schulz R., Rassaf T., Lauer T., Dejam A., Jax T., et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006, 107:2943-2951.
32. Grau M., Pauly S., Ali J., Walpurgis K., Thevis M., Bloch W., et al. R.B.C.NOS-dependent S-nitrosylation of cytoskeletal proteins improves RBC deformability. PLoS ONE 2013, 8:e56759.
33. Romero N., Denicola A., Radi R. Red blood cells in the metabolism of nitric oxide-derived peroxynitrite. IUBMB Life 2006, 58:572-580.
34. Radi R. Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects. Acc Chem Res 2013, 46:550-559.
35. Matarrese P., Straface E., Pietraforte D., Gambardella L., Vona R., Maccaglia A., et al. Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases. FASEB J 2005, 19:416-418.
36. Metere A., Iorio E., Pietraforte D., Podo F., Minetti M. Peroxynitrite signaling in human erythrocytes: synergistic role of hemoglobin oxidation and band 3 tyrosine phosphorylation. Arch Biochem Biophys 2009, 484:173-182.
37. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003, 9:169-176.
38. Rinalducci S., Marrocco C., Zolla L. Thiol-based regulation of glyceraldehyde-3-phosphate dehydrogenase in blood bank-stored red blood cells: a strategy to counteract oxidative stress. Transfusion 2014, 10.1111/trf.12855.
39. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997, 272:20313-20316.
40. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., Papassideri I.S. Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J Cell Mol Med 2007, 11:148-155.
41. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., Papassideri I.S. Membrane protein carbonylation in non-leukodepleted CPDA-preserved red blood cells. Blood Cells Mol Dis 2006, 36:279-282.
42. Antonelou M.H., Tzounakas V.L., Velentzas A.D., Stamoulis K.E., Kriebardis A.G., Papassideri I.S. Effects of pre-storage leukoreduction on stored red blood cells signaling: a time-course evaluation from shape to proteome. J. Proteomics 2012, 76:220-238.
43. Delobel J., Prudent M., Rubin O., Crettaz D., Tissot J.D., Lion N. Subcellular fractionation of stored red blood cells reveals a compartment-based protein carbonylation evolution. J. Proteomics 2012, 76:181-193.
44. Neelam S., Kakhniashvili D.G., Wilkens S., Levene S.D., Goodman S.R. Functional 20S proteasomes in mature human red blood cells. Exp Biol Med 2011, 236:580-591.
45. D'Alessandro A., Mirasole C., Zolla L. Haemoglobin glycation (Hb1Ac) increases during red blood cell storage: a MALDI-TOF mass-spectrometry-based investigation. Vox Sang 2013, 105:177-180.
46. Cohen C.M., Gascard P. Regulation and post-translational modification of erythrocyte membrane and membrane-skeletal proteins. Semin Hematol 1992, 29:244-292.
47. Manno S., Takakuwa Y., Nagao K., Mohandas N. Modulation of erythrocyte membrane mechanical function by beta-spectrin phosphorylation and dephosphorylation. J Biol Chem 1995, 270:5659-5665.
48. Manno S., Takakuwa Y., Mohandas N. Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J Biol Chem 2005, 280:7581-7587.
49. Wang C.C., Tao M., Wei T., Low P.S. Identification of the major casein kinase I phosphorylation sites on erythrocyte band 3. Blood 1997, 89:3019-3024.
50. Pantaleo A., Ferru E., Giribaldi G., Mannu F., Carta F., Matte A., et al. Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells. Biochem J 2009, 418:359-367.
51. Brunati A.M., Bordin L., Clari G., James P., Quadroni M., Baritono E., et al. Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes. Identification of primary and secondary phosphorylation sites. Blood 2000, 96:1550-1557.
52. Koshino I., Mohandas N., Takakuwa Y. Identification of a novel role for dematin in regulating red cell membrane function by modulating spectrin-actin interaction. J Biol Chem 2012, 287:35244-35250.
53. de Oliveira S., Silva-Herdade A., Saldanha C. Modulation of erythrocyte deformability by PKC activity. Clin Hemorheol Microcirc 2008, 39:363-373.
54. Ferru E., Giger K., Pantaleo A., Campanella E., Grey J., Ritchie K., et al. Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood 2011, 117:5998-6006.
55. Zipser Y., Piade A., Kosower N.S. Erythrocyte thiol status regulates band 3 phosphotyrosine level via oxidation/reduction of band 3-associated phosphotyrosine phosphatase. FEBS Lett 1997, 406:126-130.
56. Harrison M.L., Rathinavelu P., Arese P., Geahlen R.L., Low P.S. Role of band 3 tyrosine phosphorylation in the regulation of erythrocyte glycolysis. J Biol Chem 1991, 266:4106-4111.
57. Maneva A., Maneva-Radicheva L. Protein kinases and protein phosphatases as participants in signal transduction of erythrocytes. Protein kinases, InTech, Rijeka 2012, 249-286. G. Da Silva Xavier (Ed.).
58. Qin S., Kurosaki T., Yamamura H. Differential regulation of oxidative and osmotic stress induced Syk activation by both autophosphorylation and SH2 domains. Biochemistry 1998, 37:5481-5486.
59. Mallozzi C., Di Stasi M.A., Minetti M. Peroxynitrite-dependent activation of src tyrosine kinases lyn and hck in erythrocytes is under mechanistically different pathways of redox control. Free Radic Biol Med 2001, 30:1108-1117.
60. Rinalducci S., Longo V., Ceci L.R., Zolla L. Targeted quantitative phosphoproteomic analysis of erythrocyte membranes during blood bank storage. J Mass Spectrom 2015, 50:326-335.
61. Rinder H.M., Snyder E.L. Activation of platelet concentrate during preparation and storage. Blood Cells 1992, 18:445-456.
62. Skripchenko A., Kurtz J., Moroff G., Wagner S.J. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Transfusion 2008, 48:1469-1477.
63. Marcus A.J., Silk S.T., Safier L.B., Ullman H.L. Superoxide production and reducing activity in human platelets. J Clin Invest 1977, 59:149-158.
64. Finazzi-Agrò A., Menichelli A., Persiani M., Biancini G., Del Principe D. Hydrogen peroxide release from human blood platelets. Biochim Biophys Acta 1982, 718:21-25.
65. Caccese D., Praticò D., Ghiselli A., Natoli S., Pignatelli P., Sanguigni V., et al. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation-role of arachidonic acid metabolism. Thromb Haemost 2000, 83:485-490.
66. Wachowicz B., Olas B., Zbikowska H.M., Buczyński A. Generation of reactive oxygen species in blood platelets. Platelets 2002, 13:175-182.
67. Krötz F., Sohn H.Y., Pohl U. Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 2004, 24:1988-1996.
68. Seno T., Inoue N., Gao D., Okuda M., Sumi Y., Matsui K., et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res 2001, 103:399-409.
69. Krötz F., Sohn H.Y., Gloe T., Zahler S., Riexinger T., Schiele T.M., et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 2002, 100:917-924.
70. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 2011, 51:1289-1301.
71. Hayashi T., Tanaka S., Hori Y., Hirayama F., Sato E.F., Inoue M. Role of mitochondria in the maintenance of platelet function during in vitro storage. Transfus Med 2011, 21:166-174.
72. Perales Villarroel J.P., Figueredo R., Guan Y., Tomaiuolo M., Karamercan M.A., Welsh J., et al. Increased platelet storage time is associated with mitochondrial dysfunction and impaired platelet function. J Surg Res 2013, 184:422-429.
73. Schubert P., Thon J.N., Walsh G.M., Chen C.H., Moore E.D., Devine D.V., et al. A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration. Transfusion 2009, 49:1944-1955.
74. Clutton P., Miermont A., Freedman J.E. Regulation of endogenous reactive oxygen species in platelets can reverse aggregation. Arterioscler Thromb Vasc Biol 2004, 24:187-192.
75. Essex D.W., Li M. Redox control of platelet aggregation. Biochemistry 2003, 42:129-136.
76. Walsh G.M., Sheehan D., Kinsella A., Moran N., O'Neill S. Redox modulation of integrin alpha IIb beta 3 involves a novel allosteric regulation of its thiol isomerase activity. Biochemistry 2004, 43:473-480.
77. Manickam N., Ahmad S.S., Essex D.W. Vicinal thiols are required for activation of the αIIbβ3 platelet integrin. J Thromb Haemost 2011, 9:1207-1215.
78. Essex D.W., Li M., Feinman R.D., Miller A. Platelet surface glutathione reductase-like activity. Blood 2004, 104:1383-1385.
79. Burch P.T., Burch J.W. Alterations in glutathione during storage of human platelet concentrates. Transfusion 1987, 27:342-346.
80. Matsubayashi H., Weidner J., Miraglia C.C., McIntyre J.A. Platelet membrane early activation markers during prolonged storage. Thromb Res 1999, 93:151-160.
81. Arthur J.F., Gardiner E.E., Kenny D., Andrews R.K., Berndt M.C. Platelet receptor redox regulation. Platelets 2008, 19:1-8.
82. Boomgaard M.N., Gouwerok C.W., Homburg C.H., de Groot G., IJsseldijk M.J., de Korte D. The platelet adhesion capacity to subendothelial matrix and collagen in a flow model during storage of platelet concentrates for 7 days. Thromb Haemost 1994, 72:611-616.
83. Schubert P., Devine D.V. Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality. J Proteomics 2010, 73:436-444.
84. Brill A., Chauhan A.K., Canault M., Walsh M.T., Bergmeier W., Wagner D.D. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion,. Cardiovasc Res 2009, 84:137-144.
85. Canault M., Duerschmied D., Brill A., Stefanini L., Schatzberg D., Cifuni S.M., et al. p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo. Blood 2010, 115:1835-1842.
86. Gardiner E.E., Andrews R.K. Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI. Transfus Med Rev 2014, 28:56-60.
87. Skripchenko A., Awatefe H., Thompson-Montgomery D., Myrup A., Turgeon A., Wagner S.J. An inhibition of p38 mitogen activated protein kinase delays the platelet storage lesion. PLoS ONE 2013, 8:e70732.
88. Schubert P., Culibrk B., Devine D. Platelet storage lesion: analysis of molecular mechanisms by targeting protein kinases. Transfusion 2010, 50:62A.
89. Radomski M.W., Palmer R.M., Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol 1990, 101:325-328.
90. Naseem K.M. eNOS, iNOS or no NOS, that is the question!. J Thromb Haemost 2008, 6:1373-1375.
91. Langford E.J., Wainwright R.J., Martin J.F. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol 1996, 16:51-55.
92. Riddell D.R., Owen J.S. Nitric oxide and platelet aggregation. Vitam Horm 1999, 57:25-48.
93. Lohmann S.M., Walter U. Tracking functions of cGMP-dependent protein kinases (cGK). Front Biosci 2005, 10:1313-1328.
94. Kobsar A., Putz E., Yilmaz P., Weinig E., Boeck M., Koessler J. Decreasing phosphodiesterase 5A activity contributes to platelet cGMP accumulation during storage of apheresis-derived platelet concentrates. Transfusion 2014, 54:1008-1014.
95. Kobsar A., Klinker E., Kuhn S., Koessler A., Yilmaz P., Boeck M., et al. Increasing susceptibility of nitric oxide-mediated inhibitory platelet signaling during storage of apheresis-derived platelet concentrates. Transfusion 2014, 54:1782-1789.
96. Olas B., Wachowicz B. Role of reactive nitrogen species in blood platelet functions. Platelets 2007, 18:555-565.
97. Wong K., Li X. Nitric oxide infusion alleviates cellular activation during preparation, leukofiltration and storage of platelets. Transfus Apher Sci 2004, 30:29-39.
98. Park J.W., Piknova B., Kurtz J., Seetharaman S., Wagner S.J., Schechter A.N. Effect of storage on levels of nitric oxide metabolites in platelet preparations. Transfusion 2013, 53:637-644.
99. Feys H.B., Vandekerckhove P., Compernolle V. Nitric oxide levels increase during platelet concentrate production from buffy coats, but not during storage. Transfusion 2013, 53:233-234.
100. Delobel J., Rubin O., Prudent M., Crettaz D., Tissot J.D., Lion N. Biomarker analysis of stored blood products: emphasis on pre-analytical issues. Int. J. Mol. Sci 2010, 11:4601-4617.